Cardiology Information System Market by System (Standalone, Integrated System, Cardiology Information System, Cardiology PACS), Component (Software, Services, Hardware), & End User (L3A Hospital, L3B and L2 Hospital) - China Forecast to 2024
“The China cardiology information system market is projected to register a CAGR of 8.9% during the forecast period.”
The China cardiology information system market is projected to reach USD 54 million by 2024 from USD 35 million in 2019, at a CAGR of 8.9%. Growth in this market is driven by the increasing use of medical imaging modalities due to the rising incidence of cardiovascular disease, an increasing number of hospitals in China, and government initiatives for HCIT development. On the other hand, integration and interoperability issues pose a major challenge in this market.
“The integrated systems segment will witness the highest growth during the forecast period.”
Based on system, the China cardiology information system market is segmented into integrated and standalone systems. The integrated systems segment is projected to grow at the highest CAGR during the forecast period. Their cost-effectiveness and potential for workflow efficiency have contributed to their adoption.
“The Software segment will register the highest growth in the China cardiology information system market during the forecast period.”
Based on component, the China cardiology information system market is segmented into software, services, and hardware. The software segment is projected to witness the highest growth in the China cardiology information system market during the forecast period. The growing need to integrate CVIS with C-PACS, EMRs, and other cardiology modules are the major factors supporting the growth of this segment.
“L3B and L2 hospitals are estimated to register the highest CAGR during the forecast period.”
In this report, the China cardiology information system market is segmented into L3A, L3B, and L2 hospitals. The L3B and L2 hospitals segment is projected to register the highest growth rate during the forecast period, mainly due to the increasing number of such hospitals in the country.
Breakdown of Profiles of Primary Participants:
Research Coverage:
The report analyzes the China cardiology information system market by system, component, and end user. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and a forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, changes in strategic approach, and levels of output to remain successful in the market.
Key Benefits of Buying the Report:
This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
The China cardiology information system market is projected to reach USD 54 million by 2024 from USD 35 million in 2019, at a CAGR of 8.9%. Growth in this market is driven by the increasing use of medical imaging modalities due to the rising incidence of cardiovascular disease, an increasing number of hospitals in China, and government initiatives for HCIT development. On the other hand, integration and interoperability issues pose a major challenge in this market.
“The integrated systems segment will witness the highest growth during the forecast period.”
Based on system, the China cardiology information system market is segmented into integrated and standalone systems. The integrated systems segment is projected to grow at the highest CAGR during the forecast period. Their cost-effectiveness and potential for workflow efficiency have contributed to their adoption.
“The Software segment will register the highest growth in the China cardiology information system market during the forecast period.”
Based on component, the China cardiology information system market is segmented into software, services, and hardware. The software segment is projected to witness the highest growth in the China cardiology information system market during the forecast period. The growing need to integrate CVIS with C-PACS, EMRs, and other cardiology modules are the major factors supporting the growth of this segment.
“L3B and L2 hospitals are estimated to register the highest CAGR during the forecast period.”
In this report, the China cardiology information system market is segmented into L3A, L3B, and L2 hospitals. The L3B and L2 hospitals segment is projected to register the highest growth rate during the forecast period, mainly due to the increasing number of such hospitals in the country.
Breakdown of Profiles of Primary Participants:
- By Company Type: Tier 1: 20%, Tier 2: 45%, and Tier 3: 35%
- By Designation: C-level: 30%, Director-level: 20%, and Others: 50%
Research Coverage:
The report analyzes the China cardiology information system market by system, component, and end user. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and a forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, changes in strategic approach, and levels of output to remain successful in the market.
Key Benefits of Buying the Report:
This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the China cardiology information system market
- Product Development/Innovation: Detailed insights on the product approvals, R&D activities, and product launches in the China cardiology information system market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the China cardiology information system market
- Market Diversification: Exhaustive information about new products, recent developments, and investments in the China cardiology information system market
1. INTRODUCTION
1.1 INTRODUCTION
1.2 OBJECTIVES OF THE STUDY
2. RESEARCH METHODOLOGY
3. MARKET OVERVIEW
3.1 INTRODUCTION
3.2 DRIVERS
3.2.1 RISING INCIDENCE AND PREVALENCE OF CARDIOVASCULAR DISEASE IN CHINA
3.2.2 INCREASING NUMBER OF HOSPITALS IN CHINA
3.2.3 FAVORABLE GOVERNMENT INITIATIVES
3.3 OPPORTUNITIES
3.3.1 USE OF CLOUD-BASED SOLUTIONS
3.4 CHALLENGES
3.4.1 INTEGRATION AND INTEROPERABILITY
4. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY SYSTEM
4.1 INTEGRATED SYSTEMS
4.2 STANDALONE SYSTEMS
5. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY COMPONENT
5.1 SOFTWARE
5.2 SERVICES
5.3 HARDWARE
6. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY END USER ANALYSIS
6.1 INTRODUCTION
6.2 L3A HOSPITALS
6.3 L3B & L2 HOSPITALS
6.4 LEVEL 1 HOSPITALS
7. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY END USER ANALYSIS
7.1 MARKET SHARE ANALYSIS, 2018
7.2 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET SHARE ANALYSIS FOR INDIVIDUAL PLAYERS, BY HOSPITAL TYPE (2018)
8. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, COMPANY PROFILES
8.1 PHILIPS HEALTHCARE
8.1.1 COMPANY OVERVIEW
8.1.2 PRODUCTS OFFERED IN CHINA
8.1.3 BUSINESS OVERVIEW
8.1.4 SWOT ANALYSIS
8.1.5 STRATEGY
8.2 CREALIFE MEDICAL TECHNOLOGY
8.2.1 COMPANY OVERVIEW
8.2.2 PRODUCTS OFFERED IN CHINA
8.2.3 SWOT ANALYSIS
8.2.4 STRATEGY
8.3 CENTRAL DATA NETWORKS
8.3.1 COMPANY OVERVIEW
8.3.2 PRODUCTS OFFERED IN CHINA
8.3.3 SWOT ANALYSIS
8.3.4 STRATEGY
8.4 ESAOTE CHINA LTD.
8.4.1 COMPANY OVERVIEW
8.4.2 PRODUCTS OFFERED IN CHINA
8.5 INFINITT HEALTHCARE CO., LTD.
8.5.1 COMPANY OVERVIEW
8.5.2 PRODUCTS OFFERED IN CHINA
9. KEY INSIGHTS FROM INDUSTRY PARTICIPANTS
10 APPENDIX
10.1 DISCUSSION GUIDE
10.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
10.3 RELATED REPORTS
10.4 AUTHORS DETAILS
1.1 INTRODUCTION
1.2 OBJECTIVES OF THE STUDY
2. RESEARCH METHODOLOGY
3. MARKET OVERVIEW
3.1 INTRODUCTION
3.2 DRIVERS
3.2.1 RISING INCIDENCE AND PREVALENCE OF CARDIOVASCULAR DISEASE IN CHINA
3.2.2 INCREASING NUMBER OF HOSPITALS IN CHINA
3.2.3 FAVORABLE GOVERNMENT INITIATIVES
3.3 OPPORTUNITIES
3.3.1 USE OF CLOUD-BASED SOLUTIONS
3.4 CHALLENGES
3.4.1 INTEGRATION AND INTEROPERABILITY
4. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY SYSTEM
4.1 INTEGRATED SYSTEMS
4.2 STANDALONE SYSTEMS
5. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY COMPONENT
5.1 SOFTWARE
5.2 SERVICES
5.3 HARDWARE
6. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY END USER ANALYSIS
6.1 INTRODUCTION
6.2 L3A HOSPITALS
6.3 L3B & L2 HOSPITALS
6.4 LEVEL 1 HOSPITALS
7. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY END USER ANALYSIS
7.1 MARKET SHARE ANALYSIS, 2018
7.2 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET SHARE ANALYSIS FOR INDIVIDUAL PLAYERS, BY HOSPITAL TYPE (2018)
8. CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, COMPANY PROFILES
8.1 PHILIPS HEALTHCARE
8.1.1 COMPANY OVERVIEW
8.1.2 PRODUCTS OFFERED IN CHINA
8.1.3 BUSINESS OVERVIEW
8.1.4 SWOT ANALYSIS
8.1.5 STRATEGY
8.2 CREALIFE MEDICAL TECHNOLOGY
8.2.1 COMPANY OVERVIEW
8.2.2 PRODUCTS OFFERED IN CHINA
8.2.3 SWOT ANALYSIS
8.2.4 STRATEGY
8.3 CENTRAL DATA NETWORKS
8.3.1 COMPANY OVERVIEW
8.3.2 PRODUCTS OFFERED IN CHINA
8.3.3 SWOT ANALYSIS
8.3.4 STRATEGY
8.4 ESAOTE CHINA LTD.
8.4.1 COMPANY OVERVIEW
8.4.2 PRODUCTS OFFERED IN CHINA
8.5 INFINITT HEALTHCARE CO., LTD.
8.5.1 COMPANY OVERVIEW
8.5.2 PRODUCTS OFFERED IN CHINA
9. KEY INSIGHTS FROM INDUSTRY PARTICIPANTS
10 APPENDIX
10.1 DISCUSSION GUIDE
10.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
10.3 RELATED REPORTS
10.4 AUTHORS DETAILS
LIST OF TABLES
TABLE 1 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET, BY SYSTEM, 2017–2024 (USD MILLION)
TABLE 2 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 3 NUMBER OF HOSPITALS IN CHINA, 2009–2024
TABLE 4 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 5 INCREASING NUMBER OF L3A HOSPITALS IN CHINA, 2009–2024
TABLE 6 INCREASING NUMBER OF L3B & L2 HOSPITALS IN CHINA, 2009–2024
TABLE 7 CHINA: AVERAGE SELLING PRICE OF CARDIOVASCULAR INFORMATION TECHNOLOGY, BY END USER (USD MILLION)
TABLE 1 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET, BY SYSTEM, 2017–2024 (USD MILLION)
TABLE 2 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 3 NUMBER OF HOSPITALS IN CHINA, 2009–2024
TABLE 4 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 5 INCREASING NUMBER OF L3A HOSPITALS IN CHINA, 2009–2024
TABLE 6 INCREASING NUMBER OF L3B & L2 HOSPITALS IN CHINA, 2009–2024
TABLE 7 CHINA: AVERAGE SELLING PRICE OF CARDIOVASCULAR INFORMATION TECHNOLOGY, BY END USER (USD MILLION)
LIST OF FIGURES
FIGURE 1 DATA TRIANGULATION METHODOLOGY
FIGURE 2 MORTLITY RATE DUE TO HEART DISEASE IN CHINA
FIGURE 3 NUMBER OF HOSPITALS IN CHINA (IN THOUSAND)
FIGURE 4 PRIVATE VS. PUBLIC HOSPITALS IN CHINA (IN THOUSAND)
FIGURE 5 HEALTHCARE EXPENDITURE IN CHINA (IN USD)
FIGURE 6 CHINA CARDIOLOGY INFORMATION TECHNOLOGY MARKET SHARE ANALYSIS BY KEY PLAYERS, 2018
FIGURE 7 CHINA CARDIOLOGY INFORMATION TECHNOLOGY MARKET SHARE ANALYSIS FOR INDIVIDUAL PLAYERS BY HOSPITAL TYPE, 2018
FIGURE 8 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2018)
FIGURE 1 DATA TRIANGULATION METHODOLOGY
FIGURE 2 MORTLITY RATE DUE TO HEART DISEASE IN CHINA
FIGURE 3 NUMBER OF HOSPITALS IN CHINA (IN THOUSAND)
FIGURE 4 PRIVATE VS. PUBLIC HOSPITALS IN CHINA (IN THOUSAND)
FIGURE 5 HEALTHCARE EXPENDITURE IN CHINA (IN USD)
FIGURE 6 CHINA CARDIOLOGY INFORMATION TECHNOLOGY MARKET SHARE ANALYSIS BY KEY PLAYERS, 2018
FIGURE 7 CHINA CARDIOLOGY INFORMATION TECHNOLOGY MARKET SHARE ANALYSIS FOR INDIVIDUAL PLAYERS BY HOSPITAL TYPE, 2018
FIGURE 8 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2018)
